BERLIN, April 12 (LabNews.io) – Germany’s healthcare system could maintain core operations including hospital power and emergency services for up to 90 days in the event of a prolonged blockade of the Strait of Hormuz, thanks to mandatory strategic oil reserves, but pharmaceutical supply chains face earlier disruptions from rising costs and potential shortages of key raw materials.
Germany holds emergency petroleum stocks managed by the Erdölbevorratungsverband (EBV) equivalent to at least 90 days of net imports of crude oil and refined products, in line with EU and International Energy Agency requirements. These include significant volumes of diesel, heating oil and kerosene, stored decentralised across the country for rapid access. In March, Germany released around 19.5 million barrels as part of a record IEA-coordinated drawdown of 400 million barrels to ease price spikes from Middle East tensions.
Oil for electricity generation plays a minor role in Germany, with the system relying mainly on renewables, coal, gas and nuclear. Hospitals depend on diesel for backup generators and ambulance fleets, but legal provisions allow prioritised allocation of reserves to critical infrastructure during supply crises. Officials have repeatedly stated there is no immediate physical shortage of fuel.
The greater vulnerability lies in pharmaceuticals and medical supplies. A large share of active pharmaceutical ingredients (APIs) used in Europe comes from Asia, particularly India and China, with indirect exposure to Gulf petrochemical feedstocks and shipping routes. Industry representatives from Pharma Deutschland warned in early April that the conflict is already straining supply chains for medications and packaging that rely on regional raw materials, including ammonia, phosphate, sulfur and helium.
Helium, partly sourced from Gulf producers, is essential for certain production processes, MRI machines and medical gases. Disruptions could delay manufacturing and increase costs, with risks of temporary shortages in generics and other drugs growing the longer the blockade persists. No immediate widespread shortages have been reported, but the sector has flagged mounting pressures on transportation and material availability.
Medical devices such as gloves, infusion bags and catheters, which depend on petrochemical plastics, face similar indirect risks from higher oil prices and logistics bottlenecks.
Germany’s direct oil imports from the Middle East are limited, with major suppliers including Norway, the United States and Kazakhstan. A Hormuz blockade would primarily affect global markets through higher prices and rerouting, rather than cutting off physical deliveries to Germany in the short term.
Health Minister and economy officials have emphasised that emergency measures, including reserve releases and prioritisation, can mitigate immediate impacts on patient care. However, prolonged disruption beyond several weeks would likely amplify cost pressures and selective supply constraints in the pharmaceutical sector.
The actual duration the system can operate without significant strain depends on the blockade’s length, global market responses and government interventions. No official scenario studies publicly quantify an exact „collapse“ timeline for healthcare services.
